Henrik Kristian Moltke

Henrik Kristian Moltke

Président chez
Dermaveris ApS
68 ans
Health Technology
Commercial Services
Transportation

Profil

Henrik Kristian Moltke currently works at Dermaveris ApS, as Chairman, Werner Richter Og Hustrus Legat, as Chairman, StemCare A, as Director, and StemCare Danmark A, as Director.
Mr. Moltke also formerly worked at EntomoPharm ApS, as Chief Executive Officer, Initiator Pharma A, as Independent Director from 2016 to 2025, NTG Nordic Transport Group A, as Director-Investor Relations & Communications, Sjælsø Gruppen A, as Director, Hartmanns A, as Director from 1998 to 2022, Biosergen AB, as Independent Director from 2021 to 2024, Astion Pharma A, as Chief Financial Officer & Executive Vice President, Fluxome Sciences A, as Chief Financial Officer, Acesion Pharma ApS, as Chief Financial Officer, Allarity Therapeutics A, as Senior Vice President in 2020, and FluoGuide A, as Chief Financial Officer from 2020 to 2022.
Mr. Moltke received his graduate degree from Copenhagen Business School.

Postes actifs de Henrik Kristian Moltke

SociétésPosteDébut
Dermaveris ApS
Président -
Directeur/Membre du Conseil -
StemCare Danmark A/S
Directeur/Membre du Conseil -
Werner Richter Og Hustrus Legat
Président -

Anciens postes connus de Henrik Kristian Moltke

SociétésPosteFin
INITIATOR PHARMA A/S Directeur/Membre du Conseil 23/05/2025
BIOSERGEN AB Directeur/Membre du Conseil 14/06/2024
FLUOGUIDE A/S Directeur Financier/CFO 15/11/2022
Directeur/Membre du Conseil 01/06/2022
Directeur Financier/CFO 04/11/2020
Voir l'expérience en détail de Henrik Kristian Moltke

Formation de Henrik Kristian Moltke

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

13

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Transportation

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Dermaveris ApS

StemCare Danmark A/S

Health Technology

Werner Richter Og Hustrus Legat

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Henrik Kristian Moltke
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT